Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2026-01-04 @ 11:44 PM
Study NCT ID:
NCT06439693
Status:
RECRUITING
Last Update Posted:
2025-06-26
First Post:
2024-05-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-08-08
Start Date Type:
ACTUAL
Primary Completion Date:
2030-03-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2033-03-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-28
First Submit QC Date:
None
Study First Post Date:
2024-06-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-23
Last Update Post Date:
2025-06-26
Last Update Post Date Type:
ACTUAL